Gene expression in Pseudomonas aeruginosa biofilms (original) (raw)

References

  1. Costerton, J. W., Lewandowski, Z., Caldwell, D. E., Korber, D. R. & Lappin-Scott, H. M. Microbial biofilms. Annu. Rev. Microbiol. 49, 711–745 (1995).
    Article CAS Google Scholar
  2. Costerton, J. W., Stewart, P. S. & Greenberg, E. P. Bacterial biofilms: a common cause of persistent infections. Science 284, 1318–1322 (1999).
    Article ADS CAS Google Scholar
  3. Burns, J. L., Ramsey, B. W. & Smith, A. L. Clinical manifestations and treatment of pulmonary infections in cystic fibrosis. Adv. Pediatr. Infect. Dis. 8, 53–66 (1993).
    CAS PubMed Google Scholar
  4. DeBeer, D., Stoodley, P. & Lewandowski, Z. Liquid flow in heterogenous biofilms. Biotech. Bioeng. 44, 636–641 (1994).
    Article CAS Google Scholar
  5. Lawrence, J. R., Korber, D. R., Hoyle, B. D., Costerton, J. W. & Caldwell, D. E. Optical sectioning of microbial biofilms. J. Bacteriol. 173, 6558–6567 (1991).
    Article CAS Google Scholar
  6. Hoiby, N. Antibiotic therapy for chronic infection of pseudomonas in the lung. Annu. Rev. Med. 44, 1–10 (1993).
    Article CAS Google Scholar
  7. Singh, P. K. et al. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407, 762–764 (2000).
    Article ADS CAS Google Scholar
  8. O'Toole, G. A. & Kolter, R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30, 295–304 (1998).
    Article CAS Google Scholar
  9. Bangera, M. G., Ichikawa, J. K., Marx, C. & Lory, S. in Am. Soc. Microbiol. 100th Gen. Meeting (ASM Press, Los Angeles, 2000).
    Google Scholar
  10. Costerton, J. W. et al. Biofilms, the customized microniche. J. Bacteriol. 176, 2137–2142 (1994).
    Article CAS Google Scholar
  11. Stover, C. K. et al. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406, 959–964 (2000).
    Article ADS CAS Google Scholar
  12. Hill, D. F., Short, N. J., Perham, R. N. & Petersen, G. B. DNA sequence of the filamentous bacteriophage Pf1. J. Mol. Biol. 218, 349–364 (1991).
    Article CAS Google Scholar
  13. Zabriskie, J. B. Viral-induced bacterial toxins. Annu. Rev. Med. 17, 337–350 (1966).
    Article CAS Google Scholar
  14. Johnson, J. A., Morris, J. G. & Kaper, J. B. Gene encoding zonula occludens toxin (zot) does not occur independently from cholera enterotoxin genes (ctx) in Vibrio cholerae. J. Clin. Microbiol. 31, 732–733 (1993).
    CAS PubMed PubMed Central Google Scholar
  15. Greenberg, E. P. Bacterial genomics: Pump up the versatility. Nature 406, 947–948 (2000).
    Article ADS CAS Google Scholar
  16. Hancock, R. E. W. Alterations in outer membrane permeability. Annu. Rev. Microbiol. 38, 237–264 (1984).
    Article CAS Google Scholar
  17. Nikaido, H. & Vaara, M. Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49, 872–878 (1985).
    Google Scholar
  18. Bryan, L. E. & Kwan, S. Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob. Agents Chemother. 23, 835–845 (1983).
    Article CAS Google Scholar
  19. Bryan, L. E., Nicas, T., Holloway, B. W. & Crowther, C. Aminoglycoside-resistant mutation of Pseudomonas aeruginosa defective in cytochrome _c_552 and nitrate reductase. Antimicrob. Agents Chemother. 17, 71–79 (1980).
    Article CAS Google Scholar
  20. Damper, P. D. & Epstein, W. Role of membrane potential in bacterial resistance to aminoglycoside antibiotics. Antimicrob. Agents Chemother. 20, 803–808 (1981).
    Article CAS Google Scholar
  21. Bryan, L. E., Haraphongse, R. & Elzen, H. M. V. D. Gentamicin resistance in clinical-isolates of Pseudomonas aeruginosa associated with diminished gentamicin accumulation and no detectable enzymatic modification. J. Antibiot. (Tokyo) 29, 743–753 (1976).
    Article CAS Google Scholar
  22. MacLeod, D. L. et al. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. J. Infect. Dis. 181, 1180–1184 (2000).
    Article CAS Google Scholar
  23. Rivera, M., Hancock, R. E., Sawyer, J. G., Haug, A. & McGroarty, E. J. Enhanced binding of polycationic antibiotics to lipopolysaccharide from an aminoglycoside-supersusceptible, tolA mutant strain of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 32, 649–655 (1988).
    Article CAS Google Scholar
  24. Suh, S. J. et al. Effect of rpoS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J. Bacteriol. 181, 3890–3897 (1999).
    CAS PubMed PubMed Central Google Scholar
  25. Heydorn, A. et al. Experimental reproducibility in flow-chamber biofilms. Microbiology 146, 2409–2415 (2000).
    Article CAS Google Scholar
  26. Whiteley, M., Parsek, M. R. & Greenberg, E. P. Regulation of quorum sensing by RpoS in Pseudomonas aeruginosa. J. Bacteriol. 182, 4356–4360 (2000).
    Article CAS Google Scholar
  27. Hoiby, N. Pseudomonas in Cystic Fibrosis: Past, Present and Future 1–25 (Cystic Fibrosis Trust, Berlin, 1998).
    Google Scholar
  28. Davies, D. G. et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280, 295–298 (1998).
    Article ADS CAS Google Scholar
  29. Hentzer, M. et al. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J. Bacteriol. 183, 5395–5401 (2001).
    Article CAS Google Scholar
  30. Ichikawa, J. K. et al. Interaction of Pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs. Proc. Natl Acad. Sci. USA 97, 9659–9664 (2000).
    Article ADS CAS Google Scholar

Download references